JP2024502236A5 - - Google Patents
Info
- Publication number
- JP2024502236A5 JP2024502236A5 JP2023537307A JP2023537307A JP2024502236A5 JP 2024502236 A5 JP2024502236 A5 JP 2024502236A5 JP 2023537307 A JP2023537307 A JP 2023537307A JP 2023537307 A JP2023537307 A JP 2023537307A JP 2024502236 A5 JP2024502236 A5 JP 2024502236A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127089P | 2020-12-17 | 2020-12-17 | |
| US63/127,089 | 2020-12-17 | ||
| US202163153492P | 2021-02-25 | 2021-02-25 | |
| US63/153,492 | 2021-02-25 | ||
| PCT/US2021/064213 WO2022133317A1 (en) | 2020-12-17 | 2021-12-17 | Kits and methods for induction of cardioversion in subjects with atrial arrhythmias |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502236A JP2024502236A (ja) | 2024-01-18 |
| JP2024502236A5 true JP2024502236A5 (https=) | 2024-12-24 |
Family
ID=82058359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537307A Pending JP2024502236A (ja) | 2020-12-17 | 2021-12-17 | 心房性不整脈を有する対象におけるカルディオバージョンの誘導のためのキットおよび方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12059414B2 (https=) |
| EP (1) | EP4262764A4 (https=) |
| JP (1) | JP2024502236A (https=) |
| AU (1) | AU2021400335A1 (https=) |
| CA (1) | CA3200432A1 (https=) |
| WO (1) | WO2022133317A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020323594B2 (en) * | 2019-08-01 | 2022-02-03 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
| CA3200432A1 (en) * | 2020-12-17 | 2022-06-23 | Incarda Therapeutics, Inc. | Kits and methods for induction of cardioversion in subjects with atrial arrhythmias |
| US20260061000A1 (en) * | 2022-08-16 | 2026-03-05 | Lankenau Institute For Medical Research | Compositions and methods for the treatment of cardiac arrhythmias, including atrial fibrillation |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US20020161018A1 (en) * | 2001-02-23 | 2002-10-31 | Smith Forrest L. | Enhancement of the potency and efficacy of local anesthetics with ibutilide and other methanesulfonamide drugs |
| US6968226B2 (en) * | 2002-01-30 | 2005-11-22 | Medtronic, Inc. | Method and system for terminating an atrial arrhythmia |
| US8106099B2 (en) * | 2003-03-18 | 2012-01-31 | Sanofi-Aventis Deutschland Gmbh | Combination of phenylcarboxamides with blockers of the IKr channel and their use for the treatment of atrial arrhythmias |
| EP1781360A1 (en) * | 2004-08-12 | 2007-05-09 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| JP2008513445A (ja) * | 2004-09-20 | 2008-05-01 | コラス ファーマ インコーポレイテッド | 吸入による送達で治療効果のある薬剤の許容性の改善方法 |
| CN101262846A (zh) * | 2005-07-15 | 2008-09-10 | Map药物公司 | 在离散的吸入粒子中结合的多种活性药物成分及其制剂 |
| EP3552602B1 (en) * | 2009-03-18 | 2025-03-05 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| HK1201455A1 (en) | 2012-01-27 | 2015-09-04 | Gilead Sciences Inc | Combination therapies using late sodium ion channel blockers and potassium ion channel blockers |
| WO2013185764A2 (en) * | 2012-06-13 | 2013-12-19 | Acesion Pharma | Pharmaceutical compositions for combination therapy |
| US9597302B1 (en) * | 2015-09-24 | 2017-03-21 | Heart Rhythm Solutions, Inc. | Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation |
| CN109069495A (zh) * | 2016-02-01 | 2018-12-21 | 英凯达治疗公司 | 电子监测联合吸入药理学疗法管理包括心房颤动在内的心律失常 |
| AU2018266199A1 (en) | 2017-05-10 | 2019-11-07 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| US10744087B2 (en) | 2018-03-22 | 2020-08-18 | Incarda Therapeutics, Inc. | Method to slow ventricular rate |
| CN112533664A (zh) | 2018-06-05 | 2021-03-19 | 英凯达治疗公司 | 使用气雾剂诊断Brugada综合征的方法 |
| AU2020323594B2 (en) | 2019-08-01 | 2022-02-03 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
| US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
| CN116669715A (zh) | 2020-11-18 | 2023-08-29 | Fb-Hrs有限责任公司 | 含有多非利特和美西律的组合物及其应用 |
| CA3200432A1 (en) * | 2020-12-17 | 2022-06-23 | Incarda Therapeutics, Inc. | Kits and methods for induction of cardioversion in subjects with atrial arrhythmias |
-
2021
- 2021-12-17 CA CA3200432A patent/CA3200432A1/en active Pending
- 2021-12-17 AU AU2021400335A patent/AU2021400335A1/en active Pending
- 2021-12-17 EP EP21907959.7A patent/EP4262764A4/en active Pending
- 2021-12-17 WO PCT/US2021/064213 patent/WO2022133317A1/en not_active Ceased
- 2021-12-17 JP JP2023537307A patent/JP2024502236A/ja active Pending
-
2022
- 2022-03-30 US US17/708,732 patent/US12059414B2/en active Active
-
2023
- 2023-03-20 US US18/186,668 patent/US12576074B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502236A5 (https=) | ||
| CN101896204B (zh) | 用于治疗紫癜的组合物及方法 | |
| AU2015359346B2 (en) | Dosing regimen for a selective S1P1 receptor agonist | |
| SA96160590B1 (ar) | تركيبة صيدلانية | |
| Matana et al. | Unmasking effect of propafenone on the concealed form of the Brugada phenomenon | |
| KR20160108611A (ko) | 심방세동의 치료 방법 | |
| Tsai et al. | Myocardial protective effect of honokiol: an active component in Magnolia ofpcinalis | |
| JP2011518147A (ja) | 血中カリウム濃度を調節する薬剤を調製するためのドロネダロンまたは医薬的に許容されるこの塩の使用 | |
| US20110166221A1 (en) | Use of dronedarone for the preparation of a medicament for use in the prevention of cardioversion | |
| CN110038002B (zh) | 丹酚酸a防治肌肉萎缩、肌病及肌肉骨骼并发症的用途 | |
| Baroffio et al. | A randomised study comparing digoxin and propafenone in the treatment of recent onset atrial fibrillation | |
| AU2004238217A1 (en) | Method of treating atrial fibrillation or atrial flutter | |
| Ollivier et al. | Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension | |
| JP2957618B2 (ja) | アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物 | |
| Clement | Effect of indoramin on finger blood flow in vasospastic patients | |
| EP4203929A1 (en) | Methods and compositions for treating heart conditions | |
| HUP0100365A2 (hu) | Kombinációs terápia AIDS kezelésére | |
| EP1653937B1 (en) | Compounds useful for treating neuropathic pain and migraine | |
| JP2023504205A5 (https=) | ||
| CN104069117A (zh) | 安普那韦在制备预防或治疗缺血性心脑血管疾病的药物中的应用 | |
| EP2386300A1 (en) | Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter | |
| CN112168887A (zh) | 华佗再造丸在制备治疗稳定性劳累型心绞痛的药物中的用途 | |
| WO2012020377A1 (en) | Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation | |
| CN104096216B (zh) | 甲磺酸沙奎拉韦在制备预防或治疗缺血性心脑血管疾病的药物中的应用 | |
| Beaufort-Krol et al. | Oral propafenone as treatment for incessant supraventricular and ventricular tachycardia in children |